Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-10-04
2009-02-17
Habte, Kahsay T (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S105000
Reexamination Certificate
active
07491719
ABSTRACT:
Enantiomerically pure compounds of general formula 1wherein the groups R1, R2, R3, R4, and X−may have the meanings given in the claims and in the specification, processes for preparing them and the use thereof as pharmaceutical compositions, particularly as pharmaceutical compositions for the treatment of respiratory complaints.
REFERENCES:
patent: 4215119 (1980-07-01), Mentrup et al.
patent: 4460581 (1984-07-01), Schromm et al.
patent: 4570630 (1986-02-01), Elliott et al.
patent: 4656168 (1987-04-01), Atkinson et al.
patent: 5035237 (1991-07-01), Newell et al.
patent: 5223614 (1993-06-01), Schromm et al.
patent: 5472143 (1995-12-01), Bartels et al.
patent: 5497944 (1996-03-01), Weston et al.
patent: 5750701 (1998-05-01), Beeley et al.
patent: 5911851 (1999-06-01), Bartels et al.
patent: 5947118 (1999-09-01), Hochrainer et al.
patent: 5964416 (1999-10-01), Jaeger et al.
patent: 6007676 (1999-12-01), Bartels et al.
patent: 6176442 (2001-01-01), Eicher et al.
patent: 6453795 (2002-09-01), Eicher et al.
patent: 6503362 (2003-01-01), Bartels et al.
patent: 6582678 (2003-06-01), Staniforth
patent: 6706726 (2004-03-01), Meissner et al.
patent: 6747154 (2004-06-01), Brandenburg et al.
patent: 6846413 (2005-01-01), Kadel et al.
patent: 6951888 (2005-10-01), Buettner et al.
patent: 7056916 (2006-06-01), Konetzki et al.
patent: 7084153 (2006-08-01), Banholzer et al.
patent: 7160882 (2007-01-01), Bouyssou et al.
patent: 7220742 (2007-05-01), Lustenberger et al.
patent: 7307076 (2007-12-01), Konetzki et al.
patent: 2001/0008632 (2001-07-01), Freund et al.
patent: 2002/0022625 (2002-02-01), Walland et al.
patent: 2003/0018019 (2003-01-01), Meade et al.
patent: 2003/0152523 (2003-08-01), Martin et al.
patent: 2004/0002502 (2004-01-01), Banholzer et al.
patent: 2004/0010003 (2004-01-01), Banholzer et al.
patent: 2004/0024007 (2004-02-01), Pairet et al.
patent: 2004/0044020 (2004-03-01), Meade et al.
patent: 2004/0048886 (2004-03-01), Meade et al.
patent: 2004/0048887 (2004-03-01), Meade et al.
patent: 2004/0058950 (2004-03-01), Meade et al.
patent: 2004/0166065 (2004-08-01), Schmidt
patent: 2004/0228805 (2004-11-01), Pieper et al.
patent: 2005/0004228 (2005-01-01), Konetzki
patent: 2005/0008578 (2005-01-01), Schmidt
patent: 2005/0025718 (2005-02-01), Meade et al.
patent: 2005/0101625 (2005-05-01), Boeck et al.
patent: 2005/0137242 (2005-06-01), Walland et al.
patent: 2005/0154006 (2005-07-01), Meade et al.
patent: 2005/0186175 (2005-08-01), Meade et al.
patent: 2005/0222144 (2005-10-01), Konetzki et al.
patent: 2005/0239778 (2005-10-01), Konetzki et al.
patent: 2005/0255050 (2005-11-01), Trunk
patent: 2005/0256114 (2005-11-01), Grauert et al.
patent: 2005/0256115 (2005-11-01), Aven
patent: 2005/0272726 (2005-12-01), Konetzki et al.
patent: 2006/0063817 (2006-03-01), Bouyssou et al.
patent: 2006/0106213 (2006-05-01), Konetzki et al.
patent: 2006/0189607 (2006-08-01), Konetzki et al.
patent: 2007/0066609 (2007-03-01), Bouyssou et al.
patent: 2007/0086957 (2007-04-01), Bouyssou et al.
patent: 2007/0088030 (2007-04-01), Niklaus-Humke et al.
patent: 2007/0088160 (2007-04-01), Krueger et al.
patent: 2007/0155741 (2007-07-01), Konetzki et al.
patent: 2008/0041369 (2008-02-01), Radau et al.
patent: 2008/0041370 (2008-02-01), Radau et al.
patent: 2164222 (1994-12-01), None
patent: 2233981 (1997-04-01), None
patent: 2237853 (1997-06-01), None
patent: 2300908 (1999-04-01), None
patent: 2405745 (2001-11-01), None
patent: 2450961 (2003-01-01), None
patent: 2455167 (2003-01-01), None
patent: 2425539 (2003-04-01), None
patent: 2425557 (2003-04-01), None
patent: 2471578 (2003-08-01), None
patent: 2479652 (2003-09-01), None
patent: 2481876 (2003-10-01), None
patent: 2506082 (2004-06-01), None
patent: 2559699 (2005-11-01), None
patent: 2562859 (2005-11-01), None
patent: 1144713 (1963-03-01), None
patent: 3625685 (1987-03-01), None
patent: 0073505 (1983-03-01), None
patent: 0237507 (1987-09-01), None
patent: 0321864 (1989-06-01), None
patent: 2106102 (1983-04-01), None
patent: 91/14468 (1991-10-01), None
patent: 94/07607 (1994-04-01), None
patent: 94/28958 (1994-12-01), None
patent: 97/12683 (1997-04-01), None
patent: 97/12687 (1997-04-01), None
patent: 97/20590 (1997-06-01), None
patent: 99/16530 (1999-04-01), None
patent: 01/58425 (2001-08-01), None
patent: 01/83462 (2001-11-01), None
patent: 02/30928 (2002-04-01), None
patent: 02/32899 (2002-04-01), None
patent: 03/000241 (2003-01-01), None
patent: 03/000265 (2003-01-01), None
patent: 03/064417 (2003-08-01), None
patent: 03/078429 (2003-09-01), None
patent: 03/084502 (2003-10-01), None
patent: WO2004/045618 (2004-03-01), None
patent: 2004/087142 (2004-10-01), None
patent: 2005/102349 (2005-11-01), None
patent: 2005/111005 (2005-11-01), None
patent: 2007/020227 (2007-02-01), None
Hamada, Takayuki, et al Practical Synthesis of Optically Active Styrene Oxides via Reductive Transformation of 2-Choloracetophenones with Chiral Rhodium Catalysts, Organic Letters 2002, vol. 4, No. 24, 4373-4376.
Armarego, W. L. F.; Purification of Laboratory Chemicals (4th Edition); (1997) p. 529; Elsevier Publisher.
Babin, D. et al; Biomimetic Synthesis of Chrysanthemol; (1981) vol. 37. No. 2 pp. 325-332.
Balzano, G. et al; “Effectiveness and Acceptability of a Domiciliary Multidrug Inhalation Treatment in Elderly Patients with Chronic Airflow Obstruction: Metered Dose Inhaler Versus Jet Nebulizer”; J. of Aerosol Medicine (2000) vol. 13, No. 1, 2000, pp. 25-33.
Bedi, Rajinder Singh; Inhaled Corticosteroids in COPD; Indian Journal Chest Dis Allied Sci (2005) vol. 47, pp. 243-244.
Buu-Hoi, N. P. et al; Alpha, Alpha-Dimethyl-Beta-Arylethymanines, and Their Behavior in the Bischler-Napieralski Reaction; Journal of Organic Chemistry (1958) vol. 23, No. 1 pp. 42-45.
Chronic Obstructive Pulmonary Disease (Wikepedia) Jul. 3, 2008.
Coutts, Ronald T. et al; Synthesis of Two in Vivo Metabolites of N-(N-Propyl)Phentermine; Canadian Journal of Chemistry (1978) vol. 56 pp. 3054-3058.
Crapo, James D. et al; Beta-Adrenergic Receptor Agonists; Baum's Textbook of Pulmonary Disease.
Declaration of Dr. Andreas Schnapp Under 37 C.F.R. § 1.132 submitted in U.S. Appl. No. 11/109,030 filed Apr. 19, 2005.
Dutu, S. et al; Lung Function In COPD Patients Under Long Term Inhaled Therapy With Bronchodilator Agents and Beclometasone, European Respiratory Journal, (1997) Supp., Bd. 10, Nr. 25, Supp. 20.
Gavezzotti, “Are Crystal Structures Predictable?” Accounts of Chemical Research, vol. 27, pp. 309-314 (1994).
Gina: Global Initiative for Asthma: Pocket Guide for Asthma Management and Prevention (2005) 30 pages.
Griesser, Ulrich J.; The Importance of Solvates; Polymorphism: in the Pharmaceutical Industry (2006) chapter 8; pp. 211-233.
Jackson, Catherine M. et al; Benefit-Risk Assessment of Long-Acting B2-Agonists in Asthma; Drug Safety 2004 vol. 27 No. 4 pp. 243-270.
Klimanskaya, E.V.; Chronic Obstructive Lung Diseases in Children; http://www.nedug.ru/lib/lit/therap/01oct/therap204/therap.htm (2008) pp. 1-5.
Martinez, Fernando J. et al; Is It Asthma or COPD? Postgraduate Medicine Online (2005) vol. 117, No. 3, pp. 1-13.
Merck Manual Home Edition; Respiratory Distress Syndrome; Acidosis; Pneumococcal Infections; Lung Cancer and Severe Acute Respiratory Syndrome (SARS); retrieved Jun. 10, 2007.
O'Byrne, Paul M. et al; Inhaled Beta 2-Agonists in the Treatment of Asthma; The New England Journal of Medicine (1996) vol. 335 No. 12 pp. 886-888.
Sereda, V.P., et al; Inhalation Therapy of Chronic Obstructive Lung Diseases; www.pharmindex.ru/practic/4—pulmo.html. pp. 1-35.
Sovani, Milind P. et al; A Benefit-Risk Assessment of Inhaled Long-Acting B2-Agonists in the Management of Obstructive Pulmonary Disease; Drug Safety 2004 vol. 27 No. 10 pp. 689-715.
Timberlake, Jack W. et al; Thiadiaziridine 1,1-Dioxides: Synthesis and Chemistry; Journal of Organic Chemistry (1981) vol. 46, No. 10 pp. 2082-2089; American Chemical Society.
Ukena, D.; Ciclesonide—A New Inhaled Corticosteroid. Pharmacological Properties and Clinical Efficacy in the Treatment of Asthma; Pneumalogie (20
Konetzki Ingo
Lustenberger Philipp
Sieger Peter
Boehringer Ingelheim International GmbH
Habte Kahsay T
Lebel Edouard G.
Morris Michael P.
Witkowski Timothy X.
LandOfFree
Enantiomerically pure beta agonists, process for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enantiomerically pure beta agonists, process for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enantiomerically pure beta agonists, process for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4126879